145 related articles for article (PubMed ID: 10929004)
21. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc.
Rye PD; Bovin NV; Vlasova EV; Walker RA
Glycobiology; 1995 Jun; 5(4):385-9. PubMed ID: 7579792
[TBL] [Abstract][Full Text] [Related]
23. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
Springer GF; Desai PR
Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
[TBL] [Abstract][Full Text] [Related]
24. Lectin from Beauveria bassiana mycelium recognizes Thomsen-Friedenreich antigen and related structures.
Kossowska B; Lamer-Zarawska E; Olczak M; Katnik-Prastowska I
Comp Biochem Physiol B Biochem Mol Biol; 1999 May; 123(1):23-31. PubMed ID: 10425710
[TBL] [Abstract][Full Text] [Related]
25. Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr).
Wu AM; Wu JH; Yang Z; Singh T; Goldstein IJ; Sharon N
Biochimie; 2008; 90(11-12):1769-80. PubMed ID: 18809460
[TBL] [Abstract][Full Text] [Related]
26. Effect of polyvalencies of glycotopes on the binding of a lectin from the edible mushroom, Agaricus bisporus.
Wu AM; Wu JH; Herp A; Liu JH
Biochem J; 2003 Apr; 371(Pt 2):311-20. PubMed ID: 12467495
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
28. Use of synthetic antigens with the carbohydrate structure of asialoglycophorin A for the specification of Thomsen-Friedenreich antibodies.
Höppner W; Fischer K; Poschmann A; Paulsen H
Vox Sang; 1985; 48(4):246-53. PubMed ID: 3984310
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
Butschak G; Karsten U
Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Thomsen-Friedenreich antibody subpopulations from normal human serum.
Wolf MF; Koerner U; Klumpp B; Schumacher K
Tumour Biol; 1987; 8(5):264-72. PubMed ID: 3448772
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.
Kagan E; Ragupathi G; Yi SS; Reis CA; Gildersleeve J; Kahne D; Clausen H; Danishefsky SJ; Livingston PO
Cancer Immunol Immunother; 2005 May; 54(5):424-30. PubMed ID: 15625606
[TBL] [Abstract][Full Text] [Related]
32. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
34. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
Ragupathi G; Koganty RR; Qiu D; Lloyd KO; Livingston PO
Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
[TBL] [Abstract][Full Text] [Related]
35. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP
Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391
[TBL] [Abstract][Full Text] [Related]
36. Recognition profile of Morus nigra agglutinin (Morniga G) expressed by monomeric ligands, simple clusters and mammalian polyvalent glycotopes.
Singh T; Wu JH; Peumans WJ; Rougé P; Van Damme EJ; Wu AM
Mol Immunol; 2007 Jan; 44(4):451-62. PubMed ID: 16581130
[TBL] [Abstract][Full Text] [Related]
37. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
Wu J; Guo Z
Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
[TBL] [Abstract][Full Text] [Related]
38. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO
Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472
[TBL] [Abstract][Full Text] [Related]
39. Thomsen-friedenreich disaccharide immunogenicity.
Irazoqui FJ; Nores GA
Curr Cancer Drug Targets; 2003 Dec; 3(6):433-43. PubMed ID: 14683501
[TBL] [Abstract][Full Text] [Related]
40. [Monospecific antibodies against synthetic T-antigen. Characteristics of their specificity and use in the identification of T-antigenic determinants on the cell surface].
Medvedev AE; Gabriélian ND; Bovin NV; Khorlin AIa
Bioorg Khim; 1985 Jul; 11(7):908-19. PubMed ID: 2413865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
